Danaher PE Ratio 2010-2023 | DHR
Current and historical p/e ratio for Danaher (DHR) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Danaher PE ratio as of May 15, 2024 is 32.09.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Danaher PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2024-05-15 |
263.46 |
|
41.23 |
| 2023-12-31 |
231.09 |
$6.39 |
36.16 |
| 2023-09-30 |
247.27 |
$7.93 |
31.18 |
| 2023-06-30 |
239.19 |
$8.52 |
28.07 |
| 2023-03-31 |
250.91 |
$9.28 |
27.04 |
| 2022-12-31 |
263.94 |
$9.65 |
27.35 |
| 2022-09-30 |
256.61 |
$9.05 |
28.36 |
| 2022-06-30 |
251.63 |
$8.49 |
29.64 |
| 2022-03-31 |
290.86 |
$8.64 |
33.66 |
| 2021-12-31 |
325.96 |
$8.62 |
37.81 |
| 2021-09-30 |
301.42 |
$7.89 |
38.20 |
| 2021-06-30 |
265.52 |
$7.51 |
35.36 |
| 2021-03-31 |
222.52 |
$6.35 |
35.04 |
| 2020-12-31 |
219.40 |
$4.87 |
45.05 |
| 2020-09-30 |
212.51 |
$4.94 |
43.02 |
| 2020-06-30 |
174.36 |
$4.67 |
37.34 |
| 2020-03-31 |
136.33 |
$4.40 |
30.98 |
| 2019-12-31 |
150.98 |
$4.05 |
37.28 |
| 2019-09-30 |
141.92 |
$3.37 |
42.11 |
| 2019-06-30 |
140.27 |
$3.41 |
41.13 |
| 2019-03-31 |
129.42 |
$3.39 |
38.18 |
| 2018-12-31 |
100.95 |
$3.73 |
27.07 |
| 2018-09-30 |
106.21 |
$3.89 |
27.30 |
| 2018-06-30 |
96.31 |
$3.77 |
25.55 |
| 2018-03-31 |
95.41 |
$3.61 |
26.43 |
| 2017-12-31 |
90.30 |
$3.53 |
25.58 |
| 2017-09-30 |
83.32 |
$3.39 |
24.58 |
| 2017-06-30 |
81.84 |
$3.14 |
26.06 |
| 2017-03-31 |
82.81 |
$3.29 |
25.17 |
| 2016-12-31 |
75.24 |
$3.66 |
20.56 |
| 2016-09-30 |
75.65 |
$3.58 |
21.13 |
| 2016-06-30 |
73.78 |
$5.03 |
14.67 |
| 2016-03-31 |
69.18 |
$5.06 |
13.67 |
| 2015-12-31 |
67.62 |
$4.76 |
14.21 |
| 2015-09-30 |
61.95 |
$4.69 |
13.21 |
| 2015-06-30 |
62.12 |
$3.63 |
17.11 |
| 2015-03-31 |
61.53 |
$3.61 |
17.04 |
| 2014-12-31 |
62.01 |
$3.63 |
17.08 |
| 2014-09-30 |
54.91 |
$3.82 |
14.37 |
| 2014-06-30 |
56.82 |
$3.71 |
15.32 |
| 2014-03-31 |
54.06 |
$3.63 |
14.89 |
| 2013-12-31 |
55.57 |
$3.80 |
14.62 |
| 2013-09-30 |
49.89 |
$3.58 |
13.93 |
| 2013-06-30 |
45.54 |
$3.51 |
12.97 |
| 2013-03-31 |
44.69 |
$3.48 |
12.84 |
| 2012-12-31 |
40.18 |
$3.36 |
11.96 |
| 2012-09-30 |
39.62 |
$3.27 |
12.12 |
| 2012-06-30 |
37.40 |
$3.24 |
11.54 |
| 2012-03-31 |
40.20 |
$3.34 |
12.04 |
| 2011-12-31 |
33.75 |
$3.11 |
10.85 |
| 2011-09-30 |
30.07 |
$3.00 |
10.02 |
| 2011-06-30 |
37.98 |
$3.21 |
11.83 |
| 2011-03-31 |
37.18 |
$2.82 |
13.18 |
| 2010-12-31 |
33.78 |
$2.64 |
12.82 |
| 2010-09-30 |
29.07 |
$2.35 |
12.40 |
| 2010-06-30 |
26.56 |
$1.92 |
13.83 |
| 2010-03-31 |
28.57 |
$1.82 |
15.74 |
| 2009-12-31 |
26.87 |
$1.73 |
15.53 |
| Sector |
Industry |
Market Cap |
Revenue |
| Multi-Sector Conglomerates |
Diversified Operations |
$192.030B |
$23.890B |
|
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
|
